A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis

NCT02528201 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Celecoxib 200 milligrams
DRUG: Celecoxib 400 milligrams
DRUG: diclofenac 50 milligrams

Sponsor

Pfizer